The Tel Aviv Stock Exchange was mixed today. The Tel Aviv 25 Index fell 0.12% to 1,428.63 points; the Tel Aviv 100 Index fell 0.15% to 1,236.41 points; and the BlueTech Index rose 0.39% to 324.02 points. The TelBond 20 corporate bond index rose 0.01% to 319.16 points. Trading turnover was NIS 1.08 billion.
On the foreign currency market, the Bank of Israel set the shekel-dollar representative rate up 0.208% from yesterday's rate at NIS 3.859/$, and the representative shekel-euro rate was set up 0.170% at NIS 4.37/€.
On the market, Opko Health Inc. (NYSE: OPK; TASE: OPK) rose 6.23% for the biggest rise on the Tel Aviv 25 Index following FDA approval for one of its lead drugs. Delek Group Ltd. (TASE: DLEKG) rose 1.925 on reports that a Turkey-Israel reconciliation agreement will be signed next week, possibly paving the way for Israeli natural gas exports to Turkey. Delek's gas exploration and production units Avner Oil and Gas LP (TASE: AVNR.L) and Delek Drilling LP (TASE: DEDR.L) rose 1.72% and 1.52% respectively. NICE Systems Ltd. (Nasdaq: NICE; TASE: NICE) rose 1.08%.
Mylan N.V. (Nasdaq: MYL; TASE: MYL) fell 2.10% for the biggest fall on the Tel Aviv 25 Index and Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) fell 0.75% on the day's biggest trading turnover. Elbit Systems Ltd. (Nasdaq: ESLT; TASE: ESLT) fell 1.93%. Israel Chemicals (TASE: ICL: NYSE: ICL) fell 1.14% and parent company Israel Corporation (TASE: ILCO) fell 1.08%.
Published by Globes [online], Israel business news - www.globes-online.com - on June 21, 2016
© Copyright of Globes Publisher Itonut (1983) Ltd. 2016